Determinants of medication non-adherence in Egyptian patients with systemic lupus erythematosus: Sharkia Governorate

被引:30
作者
Abdul-Sattar, Amal B. [1 ]
Abou El Magd, Sahar A. [2 ]
机构
[1] Zagazig Univ, Dept Rheumatol & Rehabil, Zagazig, Egypt
[2] Zagazig Univ, Dept Community Environm & Occupat Med, Zagazig, Egypt
关键词
Systemic lupus erythematosus; Medication non-adherence; Determinants; MODIFYING ANTIRHEUMATIC DRUGS; RHEUMATOID-ARTHRITIS; REVISED CRITERIA; ADHERENCE; DISEASE; DEPRESSION; THERAPY; QUESTIONNAIRE; VALIDATION; BELIEFS;
D O I
10.1007/s00296-014-3182-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the study was to identify the determinants of adherence to medication among Egyptian patients with SLE. A single-center cross-sectional study was conducted among Egyptian patients with SLE. Adherence to medication was measured via The Compliance Questionnaire for Rheumatology-19, and the patients were classified as non-adherers if they were taking < 80 % of their medication correctly. Predictors of adherence to SLE medication were determined by multiple logistic regressions. The mean age of participants was 30.9 +/- A 11.7 years. Females constituted 95 % of all participants. Thirty-eight (%) were taking < 80 % of their medication correctly. On logistic regression analysis, the significant independent predictors of medication non-adherence were lower educational level (OR 5.6, 95 % CI 2.1-7.3, P < 0.001), very low and low socioeconomic status (OR 2.6, 95 % CI 1.6-4.3, P < 0.04), rural residency (OR 3.4, 95 % CI 1.4-5, P < 0.01), more number of medications (OR 3.2, 95 % CI 2.3-6.9, P < 0.01), and higher depressive symptoms (OR 3.7, 95 % CI 1.4-10.2, P < 0.001). The adherence rate reported in this study was quite low. Appropriate adherence enhancing intervention strategies targeted at reducing pill load, minimizing depressive symptoms, and ensuring an uninterrupted access to free services regimen for patients with low socioeconomic status is strongly recommended. More attention should be given to SLE patients who live in rural regions.
引用
收藏
页码:1045 / 1051
页数:7
相关论文
共 47 条
[1]   Reliability and validity of systemic lupus activity measure-revised (SLAM-R) for measuring clinical disease activity in systemic lupus erythematosus [J].
Bae, SC ;
Koh, HK ;
Chang, DK ;
Kim, MH ;
Park, JK ;
Kim, SY .
LUPUS, 2001, 10 (06) :405-409
[2]  
BOYD JH, 1982, ARCH GEN PSYCHIAT, V39, P1195
[3]   Why do patients with systemic lupus erythematosus take or fail to take their prescribed medications A qualitative study in a UK cohort [J].
Chambers, S. A. ;
Raine, R. ;
Rahman, A. ;
Isenberg, D. .
RHEUMATOLOGY, 2009, 48 (03) :266-271
[4]   A systematic review of the associations between dose regimens and medication compliance [J].
Claxton, AJ ;
Cramer, J ;
Pierce, C .
CLINICAL THERAPEUTICS, 2001, 23 (08) :1296-1310
[5]   Inadequate Therapy Behavior Is Associated to Disease Flares in Patients With Rheumatoid Arthritis Who Have Achieved Remission With Disease-Modifying Antirheumatic Drugs [J].
Contreras-Yanez, Irazu ;
Ponce De Leon, Sergio ;
Cabiedes, Javier ;
Rull-Gabayet, Marina ;
Pascual-Ramos, Virginia .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2010, 340 (04) :282-290
[6]   Medication compliance feedback and monitoring in a clinical trial: Predictors and outcomes [J].
Cramer, J ;
Rosenheck, R ;
Kirk, G ;
Krol, W ;
Krystal, J .
VALUE IN HEALTH, 2003, 6 (05) :566-573
[7]   Illness perceptions in patients with systemic lupus erythematosus and proliferative lupus nephritis [J].
Daleboudt, G. M. N. ;
Broadbent, E. ;
Berger, S. P. ;
Kaptein, A. A. .
LUPUS, 2011, 20 (03) :290-298
[8]  
de Klerk E, 1999, J RHEUMATOL, V26, P2635
[9]  
de Klerk E, 2003, J RHEUMATOL, V30, P2469
[10]   Compliance with methotrexate treatment in patients with rheumatoid arthritis: influence of patients' beliefs about the medicine. A prospective cohort study [J].
de Thurah, Annette ;
Norgaard, Mette ;
Harder, Ingegerd ;
Stengaard-Pedersen, Kristian .
RHEUMATOLOGY INTERNATIONAL, 2010, 30 (11) :1441-1448